Cargando…
APOE-amyloid interaction: Therapeutic targets
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that is growing in prevalence globally. It is the only major cause of death without any effective pharmacological means to treat or slow progression. Inheritance of the ε4 allele of the Apolipoprotein (APO) E gene is the strongest...
Autores principales: | Wisniewski, Thomas, Drummond, Eleanor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118587/ https://www.ncbi.nlm.nih.gov/pubmed/32027932 http://dx.doi.org/10.1016/j.nbd.2020.104784 |
Ejemplares similares
-
Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
por: Camacho, Jessica, et al.
Publicado: (2019) -
The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis
por: Drummond, Eleanor, et al.
Publicado: (2017) -
The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
por: Drummond, Eleanor, et al.
Publicado: (2022) -
ApoE facilitates the microglial response to amyloid plaque pathology
por: Ulrich, Jason D., et al.
Publicado: (2018) -
ApoE Alzheimer’s Disease Aβ-amyloid plaque morphology varies according to APOE isotype
por: Caesar, Ina, et al.
Publicado: (2023)